Skip to main content
Vaxart, Inc. (VXRT)
OTCMKTS · Delayed Price · Currency is USD
0.755
-0.024 (-3.04%)
At close: Apr 28, 2026

Vaxart Revenue

In the year 2025, Vaxart had annual revenue of $237.26M with 726.68% growth. Vaxart had revenue of $104.24M in the quarter ending December 31, 2025, with 586.46% growth.

Revenue
237.26M
Revenue Growth
+726.68%
P/S Ratio
0.77
Revenue / Employee
3.65M
Employees
65
Market Cap
182.08M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025237.26M208.56M726.68%
Dec 31, 202428.70M21.32M288.94%
Dec 31, 20237.38M7.27M6,796.26%
Dec 31, 2022107.00K-785.00K-88.00%
Dec 31, 2021892.00K-3.15M-77.95%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Northwest Biotherapeutics 1.38M
Silence Therapeutics 559.00K
BioStem Technologies 47.48M
Nuo Therapeutics 3.31M
Harvard Apparatus Regenerative Technology 704.00K
Revenue Rankings

Vaxart News

More News